Articles tagged with Jak Stat Pathway
A study from Aarhus University found a possible link between JAK inhibitor medication and unexpected blood clots. The researchers identified a potential mechanism behind the side effect, which could lead to the development of safer medications.
Scientists at Trinity College Dublin have identified a key biological pathway, the JAK/STAT pathway, that RSV suppresses and prevents immune system igniters from activating. This discovery provides a promising new target for therapeutic immune restoration and could lead to significant impact in treating RSV infections.
A team of researchers found that immune cells maintain their alertness through the JAK-STAT signalling pathway when there is no immediate threat. This discovery could lead to new approaches for enhancing the immune system's attention and preventing autoimmune diseases.
A new study finds that rare helper T cells called Th9 can drive allergic disease and may hold the key to precision medicine approaches for treating severe allergies. Th9 cells are activated by specific transcription factors and can produce inflammatory cytokines without antigen stimulation.
Researchers discovered a cross-species signaling pathway between ticks and mammals that triggers an immune response before bacteria can infect. This pathway integrates immunity with development, providing early warning for tick-borne diseases.
A new study from National University of Singapore (NUS) researchers has demonstrated a potential method for treating advanced liver cancers like hepatocellular carcinoma (HCC). Targeting the JAK/STAT signalling pathway, they found that a class of small molecule drugs can effectively reduce cancer progression in preclinical models, with...
In a mouse model of atypical EAE, researchers found that dysregulated neutrophils cause damage and exhibit hyper-activated phenotypes, producing excessive reactive oxygen species. Neutralizing treatments reduced disease severity, highlighting the detrimental role of neutrophils in autoimmune neuroinflammation.
Researchers discovered a new candidate gene, unpaired 1, that contributes to lifespan regulation in Drosophila melanogaster. Overexpression of this gene increased lifespan in nervous tissue and fat body, but decreased lifespan in intestine.
Researchers successfully treated a patient with disfiguring sarcoidosis using a drug approved for rheumatoid arthritis. The treatment showed promising results in reducing skin lesions and halting the activation of the Jak-STAT pathway.
Researchers genetically engineered Aedes aegypti mosquitoes to resist dengue fever virus by altering the JAK/STAT pathway, resulting in a 78-83% reduction in viral copies. The modified mosquitos had normal lifespans but produced fewer eggs.
Researchers genetically modified mosquitoes to resist infection from dengue virus, boosting their natural ability to fight the disease. The findings could be a prelude to developing a strategy to eliminate the threat of dengue.
Researchers found that a JAK/STAT pathway inhibitor, AZD1480, reduces neuroinflammation and neurodegeneration in Parkinson's disease rat models. The study suggests that Jakinibs may be an important new approach to slow the progression of the disease.
The article highlights the role of pattern recognition receptors in regulating immune responses and their potential as novel targets for developing potent new therapies. The JAK/STAT signaling network also plays a crucial role in disease pathogenesis, and targeting these networks may lead to improved treatments for various diseases.
Researchers found that age-related decline in skeletal muscle stem cell function is caused by increased activation of the JAK/STAT signalling pathway. Inhibiting this pathway with specific drugs restores muscle stem cell function and promotes tissue repair.
A new study found that a microRNA named miR-279 acts through the JAK/STAT pathway to regulate locomotor activity rhythms, maintaining normal patterns of wakefulness and sleep. The researchers identified a protein called Upd as a target of miR-279, which displays daily oscillations in its secretion.
Researchers identified a novel negative regulator called eye transformer that controls the flow of information from chemical signals to genes in the cell nucleus. When this regulator is turned off, the JAK/STAT pathway hyper-activates, leading to conditions such as cancer, severe immune deficiencies, and autoimmune diseases.
Dr. George Stark receives prestigious lectureship for outstanding lifetime scientific contributions, spanning basic biochemistry and specialized fields like gene regulation and cell signaling.
Researchers found that brief periods of blocked blood flow activate a protective molecular pathway in the heart, protecting it from damage caused by restored blood flow. The study suggests that these 'mini stress tests' may help precondition and protect the heart from future attacks.
Researchers discovered a mutation in the MPL gene that activates the JAK-STAT pathway, leading to uncontrolled cell growth and leukemia. The new finding offers potential targets for drugs targeting the JAK-STAT pathway, which may be effective against leukemias caused by either the MPL or JAK2 mutations.
The JAK/STAT signaling pathway is a crucial regulator of cell growth and survival in various organisms. Research at the Cold Spring Harbor Laboratory has shed light on the molecular mechanisms underlying this pathway.